GABAPENTIN Recalls

2 recalls found for GABAPENTIN. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Recalls Gabapentin Capsules Due to Impurity Risks

Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.

GABAPENTIN
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Recalls Gabapentin Capsules Over Impurity Risk

Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg on October 10, 2025, due to failed stability testing. The recall affects capsules packaged in blister packs and sold nationwide. Consumers must stop using the product immediately and seek guidance from healthcare providers.

GABAPENTIN
Failed Impurities/Degradation
Read more

Brand Statistics

Total Recalls
2
Pages
1

Related Brands

Major PharmaceuticalsCardinal Health 107, LLC